ArticleThe Journal of experimental medicine2007

Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients.

Jérémie Decalf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.